Click the pic for Tom's website
I don’t think I made the decision to fully commit to a career in science until I was at university studying human anatomy. It was there that I came into contact with several excellent scientists whose interest in research, and neuroscience research in particular, was infectious.
I have a long-standing interest in understanding why points of communication between nerve cells (known as synapses) are particularly vulnerable across a range of diseases affecting the nervous system. A chance meeting with Kevin Talbot at a research conference led to us examining whether synapses are particularly affected in mouse models of SMA. It blossomed from there.
I would love to be an orchestral conductor or professional choral singer, although both require talent and skills that I am sadly lacking!
At home with family.
Loyal, compassionate and reliable (I’d like to think so at least)
I don’t think I could pick out one defining moment, but I would say that the most important aspect of my career has been the talented and dedicated people I have been fortunate to work alongside.
Several years ago we showed that synapses formed between nerves and muscles (known as neuromuscular junctions) are an important and early target in the disease. This has changed how researchers view the underlying causes of the disease and is helping to guide the development, targeting and testing of new therapies. More recently we found that SMA can directly affect skeletal muscle, suggesting that both nerves and muscles need to be targeted to develop treatments for SMA (click here for an article on this work).
Dresden (a really beautiful city).
Two things stand out in my memory: 1) Be open and honest, making sure you can go home and look yourself in the mirror every night. 2) Develop a tough skin, as reviews of your papers and grants are often painful.
I would have paid more attention in my A level chemistry class!
Honesty and integrity, in the absence of egotism.
Hopefully non-existent, as a complete cure will have been discovered and none of us will need to work on the disease any more. More realistically, I guess that lots of the current exciting technology and research findings will have found their way to the clinic, allowing us to build on these successes as we work towards a cure.

© 2012 JTSMA | Privacy Policy | Terms of Use
| Research | | SMA Scientist Q & A | | Tom Gillingwater Q & A |